Hepatic Adverse Effects of Fructose Consumption Independent of Overweight/Obesity

International Journal of Molecular Sciences - Tập 14 Số 11 - Trang 21873-21886
Alini Schultz1, Debora Neil1, Márcia Barbosa Águila1, Carlos Alberto Mandarim‐de‐Lacerda1
1Laboratory of Morphometry, Metabolism and Cardiovascular Disease, Biomedical Center, Institute of Biology, State University of Rio de Janeiro, Av. 28 de Setembro 87 fds, Rio de Janeiro 20551-030, Brazil

Tóm tắt

The chronic intake of fructose has been linked to insulin resistance, obesity, dyslipidemia and nonalcoholic fatty liver disease (NAFLD), which in turn, may progress to nonalcoholic steatohepatitis (NASH). We aimed to evaluate the magnitude of the effects of the chronic consumption of high-fructose (HFr) and high fat (HF) alone or combined. Four groups of male mice were fed different diets for 16 weeks: standard chow (9% fat: SC), HF diet (42% fat), HFr diet (34% fructose) and HF/HFr diet (42% fat, 34% fructose). The food intake was not different among the groups, and the body mass was not greater in the HFr group than in the SC group. The homeostasis model assessment for insulin resistance (HOMA-IR), as well as plasmatic total cholesterol and triglycerides were greater in the groups HF, HFr, and HF/HFr group than in the SC group. We observed in the groups HF, HFr and HF/HFr, compared to the group SC, nonalcoholic fatty liver disease (NAFLD) with a predominance of lipogenesis mediated by SREBP-1c and PPAR-γ, and a reduction of the oxidation mediated by PPAR-α. We also observed an increase in gluconeogenesis mediated by the GLUT-2 and the PEPCK. Importantly, we identified areas of necroinflammation indicating a transition from NAFLD to nonalcoholic steatohepatitis in the HFr and HF/HFr groups. This study is relevant in demonstrating that fructose consumption, even in the absence of obesity, causes serious and deleterious changes in the liver with the presence of the dyslipidemia, insulin resistance (IR), and NAFLD with areas of necroinflammation. These conditions are associated with a poor prognosis.

Từ khóa


Tài liệu tham khảo

Murphy, 2003, The scientific basis of recent US guidance on sugars intake, Am. J. Clin. Nutr, 78, 827S, 10.1093/ajcn/78.4.827S

Lim, 2010, The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome, Nat. Rev. Gastroenterol. Hepatol, 7, 251, 10.1038/nrgastro.2010.41

Nomura, 2012, The role of fructose-enriched diets in mechanisms of nonalcoholic fatty liver disease, J. Nutr. Biochem, 23, 203, 10.1016/j.jnutbio.2011.09.006

Aeberli, 2013, Moderate amounts of fructose consumption impair insulin sensitivity in healthy young men: A randomized controlled trial, Diabetes Care, 36, 150, 10.2337/dc12-0540

Lustig, 2012, Public health: The toxic truth about sugar, Nature, 482, 27, 10.1038/482027a

Tsuchiya, 2013, High-fat, high-fructose diet induces hepatic iron overload via a hepcidin-independent mechanism prior to the onset of liver steatosis and insulin resistance in mice, Metabolism, 62, 62, 10.1016/j.metabol.2012.06.008

Kim, 2008, Nonalcoholic fatty liver disease: A manifestation of the metabolic syndrome, Clevel. Clin. J. Med, 75, 721, 10.3949/ccjm.75.10.721

Schultz, 2012, Swimming training beneficial effects in a mice model of nonalcoholic fatty liver disease, Exp. Toxicol. Pathol, 64, 273, 10.1016/j.etp.2010.08.019

Tappy, 2010, Fructose and metabolic diseases: New findings, new questions, Nutrition, 26, 1044, 10.1016/j.nut.2010.02.014

Abdelmalek, 2012, Higher dietary fructose is associated with impaired hepatic adenosine triphosphate homeostasis in obese individuals with type 2 diabetes, Hepatology, 56, 952, 10.1002/hep.25741

Janevski, 2012, Fructose containing sugars modulate mRNA of lipogenic genes ACC and FAS and protein levels of transcription factors ChREBP and SREBP1c with no effect on body weight or liver fat, Food Funct, 3, 141, 10.1039/C1FO10111K

Coate, 2013, Hepatic glucose metabolism in late pregnancy: Normal versus high-fat and -fructose diet, Diabetes, 62, 753, 10.2337/db12-0875

Bezerra, 2000, A high fructose diet affects the early steps of insulin action in muscle and liver of rats, J. Nutr, 130, 1531, 10.1093/jn/130.6.1531

Delarue, 1996, Effects of free fatty acids on the metabolic response to oral fructose in lean healthy humans, Int. J. Obes. Relat. Metab. Disord, 20, 130

McGarry, 1995, Malonyl-CoA and carnitine palmitoyltransferase I: An expanding partnership, Biochem. Soc. Trans, 23, 481, 10.1042/bst0230481

Kawasaki, 2009, Rats fed fructose-enriched diets have characteristics of nonalcoholic hepatic steatosis, J. Nutr, 139, 2067, 10.3945/jn.109.105858

Titos, 2011, Role for PPAR-γ in obesity-induced hepatic steatosis as determined by hepatocyte- and macrophage-specific conditional knockouts, FASEB J, 25, 2538, 10.1096/fj.10-173716

Schadinger, 2005, PPAR-γ2 regulates lipogenesis and lipid accumulation in steatotic hepatocytes, Am. J. Physiol. Endocrinol. Metab, 288, E1195, 10.1152/ajpendo.00513.2004

Caton, 2011, Fructose induces gluconeogenesis and lipogenesis through a SIRT1-dependent mechanism, J. Endocrinol, 208, 273

Valera, 1994, Transgenic mice overexpressing phosphoenolpyruvate carboxykinase develop non-insulin-dependent diabetes mellitus, Proc. Natl. Acad. Sci. USA, 91, 9151, 10.1073/pnas.91.19.9151

Guillemain, 2000, The large intracytoplasmic loop of the glucose transporter GLUT2 is involved in glucose signaling in hepatic cells, J. Cell. Sci, 113, 841, 10.1242/jcs.113.5.841

Okamoto, 2002, Enhanced GLUT 2 gene expression in an oleic acid-induced in vitro fatty liver model, Hepatol. Res, 23, 138, 10.1016/S1386-6346(01)00172-3

Yamamoto, 1991, Liver and muscle-fat type glucose transporter gene expression in obese and diabetic rats, Biochem. Biophys. Res. Commun, 175, 995, 10.1016/0006-291X(91)91663-W

Alisi, 2011, Fructose at the center of necroinflammation and fibrosis in nonalcoholic steatohepatitis, Hepatology, 53, 372, 10.1002/hep.23873

Francini, 2010, Changes induced by a fructose-rich diet on hepatic metabolism and the antioxidant system, Life Sci, 86, 965, 10.1016/j.lfs.2010.05.005

Farrell, 2006, Nonalcoholic fatty liver disease: From steatosis to cirrhosis, Hepatology, 43, S99, 10.1002/hep.20973

Yoshiike, 2005, Epidemiological aspects of obesity and NASH/NAFLD in Japan, Hepatol. Res, 33, 77, 10.1016/j.hepres.2005.09.008

Malhi, 2008, Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease, Semin. Liver Dis, 28, 360, 10.1055/s-0028-1091980

Day, 2002, Pathogenesis of steatohepatitis, Best Pract. Res. Clin. Gastroenterol, 16, 663, 10.1053/bega.2002.0333

Day, 1998, Steatohepatitis: A tale of two “hits”?, Gastroenterology, 114, 842, 10.1016/S0016-5085(98)70599-2

Kohli, 2010, High-fructose, medium chain trans fat diet induces liver fibrosis and elevates plasma coenzyme Q9 in a novel murine model of obesity and nonalcoholic steatohepatitis, Hepatology, 52, 934, 10.1002/hep.23797

Takahashi, 2012, Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis, World J. Gastroenterol, 18, 2300, 10.3748/wjg.v18.i19.2300

(1996). Guide for the Care and Use of Laboratory Animals, National Academy Press.

Reeves, 1993, AIN-93 purified diets for laboratory rodents: Final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet, J. Nutr, 123, 1939, 10.1093/jn/123.11.1939

Matthews, 1985, Homeostasis model assessment: Insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man, Diabetologia, 28, 412, 10.1007/BF00280883

Mendonca, 2011, A critical analysis of three quantitative methods of assessment of hepatic steatosis in liver biopsies, Virchows Arch, 459, 477, 10.1007/s00428-011-1147-1

Aguila, 2003, Dietary effect of different high-fat diet on rat liver stereology, Liver Int, 23, 363, 10.1034/j.1478-3231.2003.00858.x

Santos, 2013, Quantitative morphology update: Image analysis, Int. J. Morphol, 31, 23, 10.4067/S0717-95022013000100003

Thông tin
Thông tin xuất bản

International Journal of Molecular Sciences

Tập 14 Số 11

21873-21886

Thông tin tác giả